Cutting Edge Cancer Treatments
Dear OncoLink "Ask the Experts,"
I am currently being treated with oxaliplatin for metastatic colon cancer in the liver. Where do you think the most promising future colon cancer help will come from angiogenesis inhibitors, monoclonal antibodies, or vaccines?
James P. Stevenson, MD, Assistant Professor of Medicine in the Hematology/Oncology Division of the University of Pennsylvania School of Medicine, responds:All of those agents (angiogenesis inhibitors, monoclonal antibodies, and vaccines) hold promise for colorectal cancer. At this point, no one agent seems to stand out. Examples of each that are being studied in colon cancer include;
- SU5416 (an antiangiogenesis drug),
- C225 (a monoclonal antibody),
- multiple vaccines directed at CEA